CervoMed Inc. (CRVO) NASDAQ
4.03
-0.015(-0.37%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.03
-0.015(-0.37%)
Currency In USD
Address
20 Park Plaza
Boston, MA 02116
United States of America (the)
Phone
617-744-4400
Website
Sector
Healthcare
Industry
Biotechnology
Employees
15
First IPO Date
May 23, 2008
| Name | Title | Pay | Year Born |
| John J. Alam | Co-Founder, Chief Executive Officer, President & Director | 807,803 | 1962 |
| Sylvie L. Gregoire | Co-Founder & Director | 42,537 | 1961 |
| Kelly Blackburn | Executive Vice President of Clinical Development | 404,940 | 1964 |
| William Robert Elder | Chief Financial Officer, General Counsel & Corporate Secretary | 548,741 | 1983 |
| Claudia Ordonez | Senior Vice President of Medical Science | 0 | 1966 |
| Marinus Verwijs | Executive Vice President of Technical Operations | 0 | 1976 |
| Mark A. De Rosch | Executive Vice President of Regulatory, Government Affairs & Program Management | 0 | 1964 |
| Matthew Winton | Chief Commercial & Business Officer | 0 | 1978 |
CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery. The company is based in Boston, Massachusetts.